Recombinant Asparaginase specifically hydrolyzes L-asparagine to aspartic acid and ammonia, deprives asparagine-dependent tumor cells of essential nutrients, and is a first-line therapeutic enzyme for acute lymphoblastic leukemia treatment.
Applications
Recombinant Asparaginase serves as a key raw material for asparagine metabolism detection kits and tumor nutrient deprivation assay reagent development.